In Uzbekistan, drug distributors are being checked due to complaints about the forcing of additional goods
The Competition Development Committee of Uzbekistan is reviewing complaints against wholesale drug suppliers who may be requiring buyers to purchase additional pharmaceuticals alongside in-demand medications. If the violations are confirmed, the companies face fines of 5% of product sales revenue for the period of the violation, but for no more than three years. According to the committee, during the first nine months of 2026, medicines in Uzbekistan […]
In Uzbekistan, drug distributors are being audited due to complaints about forcing additional products
The Competition Development Committee of Uzbekistan is reviewing appeals regarding wholesale drug suppliers who are alleged to be requiring the purchase of additional medicines alongside high-demand pharmaceuticals. If violations are confirmed, companies could face a fine of 5% of product sales revenue for the period of the violation, but for no more than three years.
According to committee data, 305 companies imported medicines into Uzbekistan in the first nine months of 2026. At the same time, the five largest suppliers accounted for 47.2% of imports.
The agency also examined changes in the pharmaceutical market. As of October 1, 2026, there were 14,598 pharmacies in the country, including 449 wholesale and 14,149 retail outlets. Of the total number of retail pharmacies, 7,940 were main locations, and another 6,209 were branches.
The committee emphasizes that forcing additional products can affect the interests of small businesses and restrain competition. Such actions may contradict the Law "On Competition."
The law prohibits forcing additional terms on counterparties when concluding contracts. In particular, a supplier has no right to make the sale of one product contingent upon the mandatory purchase of another. If the audit confirms a violation, liability measures provided by law may be applied to the companies.